Genmab A/S Postemployment Benefit Expense Defined Benefit Plans
Genmab A/S (GNMSF) reported Postemployment Benefit Expense Defined Benefit Plans of $34.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans · last filed 2026-02-17
DKK
| Period end | Postemployment Benefit Expense Defined Benefit Plans 12 month |
|---|---|
| 2024-12-31 | 205.00M DKK 6-K · filed 2025-02-12 |
| 2023-12-31 | 170.00M DKK 6-K · filed 2025-02-12 |
| 2022-12-31 | 112.00M DKK 6-K · filed 2025-02-12 |
| 2021-12-31 | 80.00M DKK 6-K · filed 2024-02-14 |
| 2020-12-31 | 51.00M DKK 6-K · filed 2023-02-22 |
| 2019-12-31 | 39.00M DKK 6-K · filed 2022-02-16 |
| 2018-12-31 | 24.00M DKK 6-K · filed 2021-02-23 |
| 2017-12-31 | 19.00M DKK 20-F · filed 2020-03-30 |
USD
| Period end | Postemployment Benefit Expense Defined Benefit Plans 12 month |
|---|---|
| 2025-12-31 | $34.00M 20-F · filed 2026-02-17 |
| 2024-12-31 | $30.00M 20-F · filed 2026-02-17 |
| 2023-12-31 | $25.00M 20-F · filed 2026-02-17 |